Wuzhou Medical released its 2026 interim report, with net profit attributable to the parent company of 15.3634 million yuan. The company's total operating revenue was 203 million yuan, down 6.40% from the same period last year. Net cash inflow from operating activities was 28.479 million yuan, down 43.05% year-on-year. The company's latest asset-liability ratio was 10.82%, gross margin was 18.08%, ROE was 2.01%, and diluted earnings per share was 0.23 yuan.
ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD.Net profit of 15.36 million yuan with revenue down 6.40% and operating cash flow down 43.05% year-on-year.
